With its teleconsultation platform intact, revoking MaNaDr’s licence could have little impact
Telemedicine revenue accounts for about US$12.8 million or 90.4% of its parent company’s total sales
Add BT as a preferred source
JUST days before Christmas, MaNaDr Clinic unwrapped a lump of coal in its stocking – confirmation that the healthcare provider’s licence to offer medical services in Singapore had been revoked.
The news was not entirely unexpected. The writing had been on the wall since Oct 24, when the Ministry of Health (MOH) first announced its intention to strip MaNaDr of its licence.
The intervening period up to last Friday (Dec 20) allowed the company to present its case to the ministry, outlining why it had fallen short, while MOH deliberated its fate.
TRENDING NOW
Indonesian court upholds earlier dismissal of 2.28 trillion rupiah claim on Keppel unit’s land
Wilmar, Musim Mas among palm-oil firms in Indonesia under probe for suspected export under-invoicing
Xi Jinping has just rewritten the rules of US-China rivalry
China traders rush for exit after cross-border flow crackdown
